Boutin Natalie T, Schecter Samantha B, Perez Emma F, Tchamitchian Natasha S, Cerretani Xander R, Gainer Vivian S, Lebo Matthew S, Mahanta Lisa M, Karlson Elizabeth W, Smoller Jordan W
Mass General Brigham Personalized Medicine, Boston, MA 02115, USA.
Brigham and Women's Hospital, Boston, MA 02115, USA.
J Pers Med. 2022 Aug 17;12(8):1323. doi: 10.3390/jpm12081323.
The Mass General Brigham Biobank (formerly Partners HealthCare Biobank) is a large repository of biospecimens and data linked to extensive electronic health record data and survey data. Its objective is to support and enable translational research focused on genomic, environmental, biomarker and family history associations with disease phenotypes. The Biobank has enrolled more than 135,000 participants, generated genomic data on more than 65,000 of its participants, distributed approximately 153,000 biospecimens, and served close to 450 institutional studies with biospecimens or data. Although the Biobank has been successful, based on some measures of output, this has required substantial institutional investment. In addition, several challenges are ongoing, including: (1) developing a sustainable cost model that doesn't rely as heavily on institutional funding; (2) integrating Biobank operations into clinical workflows; and (3) building a research resource that is diverse and promotes equity in research. Here, we describe the evolution of the Biobank and highlight key lessons learned that may inform other efforts to build biobanking efforts in health system contexts.
麻省总医院布莱根生物样本库(前身为合作伙伴医疗生物样本库)是一个大型生物样本和数据储存库,与广泛的电子健康记录数据和调查数据相关联。其目标是支持并推动专注于基因组、环境、生物标志物以及疾病表型家族史关联的转化研究。该生物样本库已招募了超过13.5万名参与者,为其中超过6.5万名参与者生成了基因组数据,分发了约15.3万个生物样本,并为近450项机构研究提供生物样本或数据。尽管该生物样本库取得了成功,但从一些产出指标来看,这需要大量的机构投资。此外,一些挑战仍在持续,包括:(1)建立一个不那么依赖机构资金的可持续成本模型;(2)将生物样本库的运营融入临床工作流程;(3)打造一个多样化且能促进研究公平性的研究资源。在此,我们描述了该生物样本库的发展历程,并强调了关键经验教训,这些经验教训可能为在卫生系统背景下开展其他生物样本库建设工作提供参考。